Search results for "TARGETS"

showing 10 items of 93 documents

New molecular targets in bone metastases.

2010

Bone metastases have a major impact on morbidity and on mortality in cancer patients. Despite its clinical relevance, metastasis remains the most poorly elucidated aspect of carcinogenesis. The biological mechanisms leading to bone metastasis establishment have been referred as " vicious circle," a complex network between cancer cells and the bone microenvironment. This review is aimed to underline the new molecular targets in bone metastases management other than bisphosphonates. Different pathways or molecules such as RANK/RANKL/OPG, cathepsin K, endothelin-1, Wnt/DKK1, Src have recently emerged as potential targets and nowadays preclinical and clinical trials are underway. The results fr…

Oncologymedicine.hormonemedicine.medical_specialtyPathologyCathepsin KProto-Oncogene Proteins pp60(c-src)Antineoplastic AgentsBone NeoplasmsBone NeoplasmAntibodies Monoclonal HumanizedEndothelinMetastasisAntineoplastic AgentEndothelinsBone metastases; Molecular targets; Animals; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antineoplastic Agents; Bone Neoplasms; Cathepsin K; Denosumab; Endothelins; Humans; Proto-Oncogene Proteins pp60(c-src); RANK Ligand; Medicine (all); Oncology; Radiology Nuclear Medicine and ImagingInternal medicineMedicineAnimalsHumansRadiology Nuclear Medicine and imagingMolecular targetbiologyAnimalbusiness.industryMedicine (all)EndothelinsRANK LigandCancerBone metastasisAntibodies MonoclonalGeneral Medicinemedicine.diseaseClinical trialBone metastaseDenosumabOncologyRANKLCancer cellbiology.proteinDenosumabbusinessHumanmedicine.drugCancer treatment reviews
researchProduct

HER2-positive male breast cancer: an update.

2010

Laura Ottini1, Carlo Capalbo2, Piera Rizzolo1, Valentina Silvestri1, Giuseppe Bronte3, Sergio Rizzo3, Antonio Russo31Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy; 2Medical Oncology, IDI-IRCCS, Rome, Italy; 3Department of Surgical and Oncological Sciences, Section of Medical Oncology, University of Palermo, Palermo, ItalyAbstract: Although rare, male breast cancer (MBC) remains a substantial cause for morbidity and mortality in men. Based on age frequency distribution, age-specific incidence rate pattern, and prognostic factor profiles, MBC is considered similar to postmenopausal breast cancer (BC). Compared with female BC (FBC), MBC cas…

Oncologymedicine.medical_specialtymedicine.medical_treatmentEstrogen receptorReviewPharmacologyLapatinibTarget therapyBreast cancerTrastuzumabInternal medicinemedicineEpidermal growth factor receptorskin and connective tissue diseasesneoplasmsNeoadjuvant therapybiologybusiness.industryLapatinibTargets and Therapy [Breast Cancer]Trastuzumabmedicine.diseaseRadiation therapyOncologyMale breast cancerbiology.proteinbusinessmedicine.drug
researchProduct

Measurement of the $\nu_{\mu}$ charged current quasi-elastic cross-section on carbon with the T2K on-axis neutrino beam

2015

17 pages.- 21 figures

Particle physicsNuclear and High Energy Physicschemistry.chemical_elementPion productionAstronomy & AstrophysicsMASSNeutrino beamPION-PRODUCTION7. Clean energy01 natural sciencesPhysics Particles & FieldsHigh Energy Physics - ExperimentNuclear physicsScatteringCross section (physics)0202 Atomic Molecular Nuclear Particle And Plasma Physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Neutron010306 general physicsNeutrino oscillationNuclear Experiment0206 Quantum PhysicsCharged currentPhysicsScience & Technologyhep-ex010308 nuclear & particles physicsScatteringPhysicsDetectorNuclear & Particles PhysicsMODEL0201 Astronomical And Space ScienceschemistryPhysical SciencesHigh Energy Physics::ExperimentNeutrinoCarbonNuclear targets
researchProduct

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of …

2013

Bernd Heinrich,* Katrin Goepfert,* Maike Delic, Peter R Galle, Markus MoehlerUniversity Medical Center of the Johannes Gutenberg University Mainz, 1st Department of Internal Medicine, Langenbeckstrasse, Mainz, Germany *These authors contributed equally to this workIntroduction: Tumor-directed and immune-system-stimulating therapies are of special interest in cancer treatment. Here, we demonstrate the potential of parvovirus H-1 (H-1PV) to efficiently kill colorectal cancer cells and induce immunogenicity of colorectal tumors by inducing maturation of dendritic cells (DCs) alone and also in combination with cytostatic drugs in vitro. Using our cell culture model, we have additionally investi…

Parvovirus H-1business.industrymedicine.medical_treatmentOncoTargets and TherapyOncolytic virusImmune systemCytokineOncologyAntigenCTLA-4ImmunologyCancer researchmedicineSW480Cytotoxic T cellPharmacology (medical)dendritic cellsbusinessTremelimumabmedicine.drugOriginal ResearchOncoTargets and Therapy
researchProduct

INFLAMMATION IN IRRITABLE BOWEL SYNDROME: MYTH OR NEW TREATMENT TARGET?

2016

Low-grade intestinal inflammation plays a key role in the pathophysiology of irritable bowel syndrome (IBS), and this role is likely to be multifactorial. The aim of this review was to summarize the evidence on the spectrum of mucosal inflammation in IBS, highlighting the relationship of this inflammation to the pathophysiology of IBS and its connection to clinical practice. We carried out a bibliographic search in Medline and the Cochrane Library for the period of January 1966 to December 2014, focusing on publications describing an interaction between inflammation and IBS. Several evidences demonstrate microscopic and molecular abnormalities in IBS patients. Understanding the mechanisms u…

Pathologymedicine.medical_specialtyMEDLINEAnti-Inflammatory AgentsInflammationCochrane LibraryBioinformaticsMast cell03 medical and health sciences0302 clinical medicineTreatment targetsGastrointestinal AgentsIntestinal inflammationmedicinePathologyAnimalsHumansMolecular Targeted TherapyTopic HighlightIntestinal MucosaIrritable bowel syndromeInflammationSettore MED/12 - GastroenterologiaMechanism (biology)business.industrySettore BIO/16 - Anatomia UmanaGastroenterologyGeneral MedicineInflammation; Irritable bowel syndrome; Mast cells; Neuroendocrine cells; Pathologymedicine.diseaseEnteritisClinical trialIrritable bowel syndromeSettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisNeuroendocrine cell030211 gastroenterology & hepatologymedicine.symptomInflammation Mediatorsbusiness
researchProduct

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investiga…

2014

Antonio Ieni,1 Valeria Barresi,1 Rosario Caltabiano,2 Anna Maria Cascone,3 Rachele Del Sordo,4 Daniela Cabibi,5 Pio Zeppa,3 Salvatore Lanzafame,2 Angelo Sidoni,4 Vito Franco,5 Giovanni Tuccari1 1Department of Human Pathology Gaetano Barresi, Section of Anatomic Pathology, University of Messina, Messina, 2Department GF Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, 3Department of Medicine and Surgery, University of Salerno, Salerno, 4Institute of Pathologic Anatomy and Histology, Division of Cancer Research, University of Perugia, Perugia, 5Department of Human Pathology, Section of Anatomic Pathology, University of Palermo, Palermo, Italy Background: Human epiderma…

Pathologymedicine.medical_specialtysynchronous lymph nodeslcsh:RC254-282OncoTargets and TherapyBreast cancer Human epidermal growth factor receptor 2 Metastases Prognosis Synchronous lymph nodesText miningBreast cancerbreast cancermedicinebreast cancer; human epidermal growth factor receptor 2; metastases; prognosis; synchronous lymph nodesPharmacology (medical)metastasesskin and connective tissue diseasesneoplasmsLymph nodeHuman Epidermal Growth Factor Receptor 2Original Researchbusiness.industryhuman epidermal growth factor receptor 2; breast cancer; synchronous lymph nodes; metastases; prognosishuman epidermal growth factor receptor 2lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemedicine.anatomical_structureOncologysynchronous lymph nodemetastaseprognosisbusinessBreast carcinoma
researchProduct

Expertise

2017

Several sets of guidelines have been published recently and more are in the works. The very recent American College of Physicians/American Academy of Family Practitioners guidelines were put together by a set of authors and consultants without any expertise in the topic under discussion, that is, hypertension. Although we are not maintaining that all guidelines should be written exclusively by experts, complete lack of expertise among guideline authors is not acceptable. ispartof: Journal Of Hypertension vol:35 issue:8 pages:1564-1566 ispartof: location:Netherlands status: published

Pediatricsmedicine.medical_specialtyhypertensionPhysiologySine qua nonAlternative medicineMEDLINE030204 cardiovascular system & hematology1102 Cardiovascular Medicine And Haematology03 medical and health sciencesProfessional Competence0302 clinical medicineInternal MedicinemedicineHumansBLOOD-PRESSURE TARGETSguidelines030212 general & internal medicineSet (psychology)Societies MedicalMETAANALYSISANGIO-EDEMAOLDERMedical educationScience & Technologybusiness.industry1103 Clinical SciencesAGED 60 YEARSGuidelineProfessional competence3. Good healthPeripheral Vascular DiseaseCardiovascular System & HematologyPractice Guidelines as TopicCardiovascular System & CardiologyexpertiseINHIBITORSCardiology and Cardiovascular MedicinebusinessLife Sciences & BiomedicineguidelineANGIO-EDEMAJournal of Hypertension
researchProduct

Gold(I) compounds with lansoprazole-type ligands

2014

A number of gold(I) complexes containing the proton pump inhibitor (PPI) lansoprazole and its reduced precursor 2-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylthio)-1H-benzo[d]imidazole have been synthesized and their biological effects have been evaluated in human cancer and nontumorigenic cells in vitro. The lansoprazole-based compounds appear to act through a V-H+-ATPase-mediated mechanism.

PharmacologyStereochemistryOrganic ChemistryLansoprazolePharmaceutical ScienceANTIPROLIFERATIVE PROPERTIESSERIESBiochemistryTUMORSIn vitroPROTON-PUMP INHIBITORSchemistry.chemical_compoundchemistryCHEMISTRYTARGETSDrug DiscoverymedicineMolecular MedicineImidazoleSOLUTION BEHAVIORCOMPLEXESAGENTSHuman cancerRESISTANCEmedicine.drugMedChemCommun
researchProduct

Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits

2021

The genus Cinnamomum includes a number of plant species largely used as food, food additives and spices for a long time. Different traditional healing systems have used these plants as herbal remedies to cure diverse ailments. The aim of this comprehensive and updated review is to summarize the biodiversity of the genus Cinnamomum, its bioactive compounds, the mechanisms that underlie the pharmacological activities and molecular targets and toxicological safety. All the data in this review have been collected from databases and recent scientific literature including Web of Science, PubMed, ScienceDirect etc. The results showed that the bioactive compounds of Cinnamomum species possess antim…

Pharmacologyclinical trialsPhytochemistryPhytochemistryTraditional medicineWeb of scienceRM1-950ReviewHealth benefitsBiologybiology.organism_classificationmechanisms of actionClinical trialsMechanisms of actionPlant speciesMolecular targetsphytochemistryPharmacology (medical)Toxicological dataTherapeutics. PharmacologyCinnamomumCiannamomum spp.
researchProduct

Spectroscopy of the neutron-deficient isobars 163 Re and 163 W using tagging techniques

2008

Bozok University;Erciyes University;et al.;Istanbul University;Nigde University;The Turkish Atomic Energy Authority (TAEK)

PhysicsNuclear Reactions 60 Ni+ 106 Cd at 270 MeV beam energy enriched targetsSpectrometerProtonYrastNuclear TheorySegmented Si and Ge detectorsNeutron spectroscopyNuclear physicsMeasured E ?IsobarNeutronGasfilled recoil separatorNuclear ExperimentGround stateRadioactive decay
researchProduct